This is an open-label, multicenter, multicohort, two-part study to confirm the dose and evaluate the safety…
Category: Studies
HIV reservoir in early-treated children
This is a cross-sectional study of clinical data and blood sample collection for HIV reservoir and…
The latent HIV reservoir in early treated Thai children
This is a prospective observational study that will characterize the HIV reservoir size and replication, and…
Natural history of hepatitis C infection, clinical significances, prognostic factors and treatment outcome/toxicity among Thai HIV-infected patients with chronic hepatitis
This is a cohort study that will use questionnaires and collect specimens/samples to assess the natural…
Evaluating pharmacokinetics interactions with vaginal ring contraceptive and ART
This study will look at a method of hormonal birth control, called the NuvaRing, and specific…
A phase 2 multiple ascending dose proof of concept study
This is a phase IIa, randomized, open-label, ascending, sequential dose group, multiple dose study of the…
Efficacy of Tenofovir Alafenamide versus placebo added to a failing regimen followed by treatment with Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide plus Atazanavir in HIV-1 positive, antiretroviral treatment-experienced adults
This is a phase III, two part study to evaluate the efficacy of Tenofovir Alafenamide versus…
Serological diagnosis of syphilis in HIV-infected patients: 10 years observation
This is a longitudinal, prospective cohort study to assess the prevalence of latent syphilis among HIV-infected…
A phase 3, randomized, double-blind study to evaluate the safety and efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate in HIV-1 positive, antiretroviral treatment-naïve adults
Randomized, Double-Blind, multicenter, active-controlled study to evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/…
Evaluation of Mobile Interactive Supervised Therapy (MIST) for monitoring adherence to TB medication
This study will assess the feasibility, acceptability and efficacy of an electronic system for monitoring and…
An international observational study to characterize adults with influenza A – pandemic H1N1 (H1N1v) INSIGHT H1N1v outpatient study (FLU 002)
The purpose of this observational study is to describe participants in geographically diverse locations with influenza…
A phase 3 open-label safety study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide single-tablet regimen in HIV-1 positive patients with mild to moderate renal impairment
Open-label, multicenter, multi-cohort study to assess the safety, tolerability, and efficacy of a STR of E/C/F/TAF…
Metabolic disease and bone health in HIV positive patients compared to HIV uninfected
This is a five-year prospective cohort study that investigates the trends of morbidity and mortality among…
A phase 2/3, open-label study of the pharmacokinetics, safety, and antiviral activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate single tablet regimen (STR) in HIV-1 infected antiretroviral treatment-naive adolescents
This study is to evaluate the steady-state pharmacokinetics (PK) and confirm the dose of the elvitegravir/cobicistat/emtricitabine/tenofovir…
A phase 2b randomized, active-controlled, staged, open-label trial to investigate safety and efficacy of BMS-955176 in combination with Dolutegravir and Atazanavir (with or without Ritonavir) in treatment-experienced HIV-1 infected adults
This study will evaluate whether the combination of BMS-955176 with atazanavir (ATV) [with or without ritonavir…
